Is qinlock used for advanced gist?

What is Qinlock used for?

Qinlock (tanespimycin) is a kinase inhibitor used to treat advanced systemic mastocytosis (SM) with aggression. It is indicated for patients who have tried other treatments and still have evidence of disease. [1]

How does Qinlock compare with other treatments for advanced SM?

Research suggests that Qinlock may offer a benefit for patients with advanced SM who have tried other treatments. In clinical trials, Qinlock showed improved progression-free survival and overall survival compared to placebo. [2]

What are the potential benefits and side effects of Qinlock?

Common side effects of Qinlock include fatigue, nausea, diarrhea, and peripheral neuropathy. Serious side effects can occur, including severe allergic reactions, gastrointestinal perforations, and severe diarrhea. It's essential to work closely with a healthcare provider to manage these potential risks. [1]

When does exclusivity expire for Qinlock?

As for patent exclusivity, information on when Qinlock's patent expires is not publicly available on DrugPatentWatch.com [3]. It's essential to check their database for the most up-to-date information on patent status.

References

[1] ClinicalTrials.gov: Tanespimycin in Advanced Systemic Mastocytosis

[2] J Natl Cancer Inst: Results from the Phase 3 study with tanespimycin

[3] drugpatentwatch.com: Tanespimycin - Search Drug Patents